Antitrust Insights for Smaller US Mergers
Non-Reportable ≠Non-ReviewableAcquisitions of U.S. companies that fall below the $80.8 million Hart-Scott-Rodino (HSR) reporting threshold may...
377 Views
Trump Health Effect: What Is Next for the Consumer Health Industry Under Trump's Leadership?
While the US consumer health industry will remain a strong centre for investment, development and technology innovation in 2017 and is expected to...
3.3k Views
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at...
594 Views
SEC and Drugmaker Allergan Reach Settlement over M&A Disclosure Violations
The U.S. Securities and Exchange Commission and drugmaker Allergan Plc (AGN US)Â settled claims that Allergan failed to disclose negotiations with...
471 Views
2017 Asset Allocation Outlook – Part 2: Trump Reflation Euphoria to Fade?
The overwhelming investor consensus a year ago was for further EM/commodity downside amid deflation fears - this year it is a USD secular bull and...
450 Views